Karen D Ersche1, Abigail J Turton, Tim Croudace, Jan Stochl. 1. Department of Psychiatry, University of Cambridge, Cambridge, UK ; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Abstract
OBJECTIVES: The drug-related locus of control scale (DR-LOC) is a new instrument for assessing a person's belief of "being in control" in situations involving drug abuse. It consists of 16-item pairs presented in a forced-choice format, based on the conceptual model outlined by Rotter. The model characterizes the extent to which a person believes that the outcome of an event is under their personal control (internal locus of control) or the influence of external circumstances (external locus of control). METHODS: A total of 592 volunteers completed the DR-LOC and the Rotter's I-E scale. Approximately half of the respondents were enrolled in a drug treatment program for opiates, stimulants and/or alcohol dependence (n = 282), and the remainder (n = 310) had no history of drug dependence. RESULTS: Factor analysis of DR-LOC items revealed 2 factors reflecting control beliefs regarding (i) the successful recovery from addiction, and (ii) decisions to use drugs. The extent to which a person attributes control in drug-related situations is significantly influenced by their personal or professional experiences with drug addiction. Drug-dependent individuals have a greater internal sense of control with regard to addiction recovery or drug-taking behaviors than health professionals and/or non-dependent control volunteers. CONCLUSIONS: The DR-LOC has shown to effectively translate generalized expectancies of control into a measure of control expectancies for drug-related situations, making it more sensitive for drug-dependent individuals than Rotter's I-E scale. Further research is needed to demonstrate its performance at discriminating between heterogeneous clinical groups such as between treatment-seeking versus non-treatment-seeking drug users.
OBJECTIVES: The drug-related locus of control scale (DR-LOC) is a new instrument for assessing a person's belief of "being in control" in situations involving drug abuse. It consists of 16-item pairs presented in a forced-choice format, based on the conceptual model outlined by Rotter. The model characterizes the extent to which a person believes that the outcome of an event is under their personal control (internal locus of control) or the influence of external circumstances (external locus of control). METHODS: A total of 592 volunteers completed the DR-LOC and the Rotter's I-E scale. Approximately half of the respondents were enrolled in a drug treatment program for opiates, stimulants and/or alcohol dependence (n = 282), and the remainder (n = 310) had no history of drug dependence. RESULTS: Factor analysis of DR-LOC items revealed 2 factors reflecting control beliefs regarding (i) the successful recovery from addiction, and (ii) decisions to use drugs. The extent to which a person attributes control in drug-related situations is significantly influenced by their personal or professional experiences with drug addiction. Drug-dependent individuals have a greater internal sense of control with regard to addiction recovery or drug-taking behaviors than health professionals and/or non-dependent control volunteers. CONCLUSIONS: The DR-LOC has shown to effectively translate generalized expectancies of control into a measure of control expectancies for drug-related situations, making it more sensitive for drug-dependent individuals than Rotter's I-E scale. Further research is needed to demonstrate its performance at discriminating between heterogeneous clinical groups such as between treatment-seeking versus non-treatment-seeking drug users.
Entities:
Keywords:
addiction recovery; drug-taking; health professionals; self-report measure; substance abuse
Authors: Antonio Verdejo-García; Antoine Bechara; Emily C Recknor; Miguel Pérez-García Journal: J Int Neuropsychol Soc Date: 2006-05 Impact factor: 2.892
Authors: Jennifer M Mitchell; Venessa C Tavares; Howard L Fields; Mark D'Esposito; Charlotte A Boettiger Journal: Neuropsychopharmacology Date: 2006-10-18 Impact factor: 7.853
Authors: Rita Z Goldstein; A D Bud Craig; Antoine Bechara; Hugh Garavan; Anna Rose Childress; Martin P Paulus; Nora D Volkow Journal: Trends Cogn Sci Date: 2009-08-27 Impact factor: 20.229
Authors: Karen D Ersche; Edward T Bullmore; Kevin J Craig; Shaila S Shabbir; Sanja Abbott; Ulrich Müller; Cinly Ooi; John Suckling; Anna Barnes; Barbara J Sahakian; Emilio V Merlo-Pich; Trevor W Robbins Journal: Arch Gen Psychiatry Date: 2010-06
Authors: Scott J Moeller; Stephen M Fleming; Gabriela Gan; Anna Zilverstand; Pias Malaker; Federico d'Oleire Uquillas; Kristin E Schneider; Rebecca N Preston-Campbell; Muhammad A Parvaz; Thomas Maloney; Nelly Alia-Klein; Rita Z Goldstein Journal: Eur Neuropsychopharmacol Date: 2016-02-10 Impact factor: 4.600
Authors: G Savulich; R Riccelli; L Passamonti; M Correia; J F W Deakin; R Elliott; R S A Flechais; A R Lingford-Hughes; J McGonigle; A Murphy; D J Nutt; C Orban; L M Paterson; L J Reed; D G Smith; J Suckling; R Tait; E M Taylor; B J Sahakian; T W Robbins; K D Ersche Journal: Transl Psychiatry Date: 2017-03-07 Impact factor: 6.222
Authors: Karen D Ersche; Abigail J Turton; Samuel R Chamberlain; Ulrich Müller; Edward T Bullmore; Trevor W Robbins Journal: Am J Psychiatry Date: 2012-09 Impact factor: 18.112